M Holdings Securities’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,943
Closed -$217K – 244
2019
Q1
$217K Buy
+1,943
New +$213K 0.05% 333
2018
Q4
– Sell
-2,727
Closed -$333K – 343
2018
Q3
$333K Sell
2,727
-455
-14% -$53.6K 0.09% 254
2018
Q2
$349K Sell
3,182
-1,929
-38% -$206K 0.1% 248
2018
Q1
$546K Buy
5,111
+135
+3% +$15K 0.17% 172
2017
Q4
$531K Buy
4,976
+344
+7% +$36.8K 0.16% 171
2017
Q3
$515K Buy
4,632
+273
+6% +$29.2K 0.16% 173
2017
Q2
$451K Buy
4,359
+735
+20% +$72.4K 0.15% 174
2017
Q1
$354K Sell
3,624
-687
-16% -$65.8K 0.14% 183
2016
Q4
$381K Sell
4,311
-837
-16% -$76.2K 0.13% 167
2016
Q3
$497K Buy
+5,148
New +$490K 0.23% 131
2014
Q4
– Sell
-6,540
Closed -$476K – 288
2014
Q3
$476K Buy
+6,540
New +$574K 0.27% 93
2014
Q1
– Sell
-8,985
Closed -$680K – 173
2013
Q4
$680K Buy
+8,985
New +$637K 0.48% 58

Other funds holding IBB

M Holdings Securities's IBB Position: Q2 2019 in Review

M Holdings Securities sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 1,943 shares — an estimated $217K sold.

M Holdings Securities first reported a position in IBB in Q4 2013 and held it in 12 quarters. The position peaked at $680K in Q4 2013. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • M Holdings Securities reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • M Holdings Securities sold 1,943 iShares Biotechnology ETF shares in Q2 2019, an estimated $217K.
  • M Holdings Securities first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 12 quarters.
  • M Holdings Securities's iShares Biotechnology ETF position peaked at $680K in Q4 2013.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on M Holdings Securities's 13F filing for Q2 2019, filed 16 Aug 2019.